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1. SUMMARY 
Src is a non-receptor tyrosine kinase which participates in many cell signalling pathways and 
its overactivation and overexpression are related to various types of human cancer. Its structure 
consists, from the N-terminus to the C-terminus, of a myristoyl group connected to the SH4 
domain, a Unique domain, the SH3 domain, the SH2 domain, the SH1 domain and a regulatory 
segment. A domain is a section of the tertiary structure of a protein that has a defined function.  
The BioNMR Group lead by Dr. Miquel Pons at the University of Barcelona has discovered 
that the intrinsically disordered region of the c-Src protein, called Unique domain, is a regulatory 
element: for example, changing one amino acid can decrease the invasive capacity of a type of 
colon cancer cells by 50%. 
The proteolysis of the Src Unique domain after stroke converts this protein from 
neuroprotective to neurotoxic. This proteolysis is catalysed by the calpain protease. Protease-
independent spontaneous proteolysis of the Unique domain in the same position has been 
observed in previous attempts to study the glycosylation of Src. It was hypothesized that this 
observation was related to environmental conditions that influence the interactions between the 
SH4 domain and the SH3 domain that cause conformational changes in the Unique domain. 
In this work we optimized conditions to study glycosylation avoiding degradation and studied 
the interaction of USH3Src with the glycolysis enzyme OGT. 
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2. RESUM 
El Src és una tirosina-cinasa no receptora, relacionada amb diversos tipus de càncer humà 
degut a la seva sobreexpressió i sobreactivació, i que participa en moltes vies de senyalització 
cel·lular. La seva estructura consisteix en, des de l’extrem N-terminal fins al C-terminal, d’un grup 
miristoil unit al domini SH4, un domini Únic, el domini SH3, el domini SH2, el domini SH1 i un 
segment regulador. Un domini és una secció de l’estructura tridimensional d’una proteïna que té 
una funció concreta. 
El Grup BioNMR dirigit pel Dr. Miquel Pons a la Universitat de Barcelona ha descobert que la 
regió intrínsecament desordenada de la proteïna Src, anomenada domini Únic, és un element de 
regulació: per exemple, el canvi d’un sol aminoàcid en aquesta regió pot disminuir en un 50% la 
capacitat invasiva d’un tipus de cèl·lules de càncer de colon. 
La proteòlisi del domini Únic del Src al patir un ictus transforma aquesta proteïna de 
neuroprotectora a neurotòxica. Aquesta proteòlisi és catalitzada per la proteasa calpain. S’han 
observat proteòlisis espontànies independentment de la presència de proteases externes en la 
mateixa posició en els intents previs d’estudiar la glicosilació de Src. S’ha arribat a la hipòtesi que 
aquestes observacions semblen dependre de condicions ambientals que afecten les interaccions 
entre el domini SH4 i el domini SH3, que provoquen canvis conformacionals en el domini Únic. 
En aquest treball s’han optimitzat les condicions per poder estudiar la glicosilació evitant la 
degradació de la proteïna i s’ha observat la interacció del USH3Src amb el OGT, l’enzim de la 
glicòlisis. 
Paraules clau: Src, tirosina-cinasa, proteòlisi, expressió i purificació de proteïnes, O-
GlcNAcetilació.   
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3. INTRODUCTION 
In this section I introduce the c-Src, a human tyrosine kinase, and the related Src Family 
Kinases (SFKs). I also talk about the discovering of c-Src, its structure and regulation and its role 
in cancer and relevance as a drug target. Finally, I will describe the O-GlcNAcylation reaction and 
its interest. 
3.1. A HISTORICAL OVERVIEW OF SRC 
Src is a hot topic nowadays with ~2.5 publications per day over the past 30 years, mostly 
because of its implication in various types of cancer. However, Src history goes a century back in 
time.  
Francis Peyton Roust, in 1911, proved that viruses can cause cancer when he worked with 
some chickens that grow a tumor called fibrosarcoma. Roust collected and ground up these 
sarcomas and then injected it into some chicks, that also developed fibrosarcoma. The causative 
agent of the infection was a virus, called the Rous Sarcoma Virus (RSV). Studies of RSV mutants 
in the early 1970s revealed its responsible oncogene, called v-Src or viral Src1. An oncogene is a 
malfunctioning gene which its uncontrollable cell growth leads to cancer. The cellular homologue 
of v-Src in humans and other species is known as c-Src or cellular Src, and it was the first proto-
oncogen to be discovered2. Proto-oncogenes are normal gens that help cells grow. 
3.2. C-SRC AND SFKS 
A protein kinase is an enzyme that catalyze the transfer of a phosphate group from ATP to a 
protein (phosphorylation). Tyrosine kinases are a subclass of protein kinase that catalyze the 
phosphorylation of tyrosine residues in proteins, which causes a change in the function of the 
protein that they are contained in. The tyrosine kinases are divided into two main families: receptor 
tyrosine kinases, which are permanently attached to membranes by a transmembrane segment, 
and non-receptor tyrosine kinases, which are reversibly anchored to the inner membrane surface. 
SFKs are included in this last group3.  
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Figure 1. Phosphorylation/desphosphorylation reactions. 
Src family kinases (SFKs) is a group of non-receptor tyrosine kinases composed by Src and 
nine additional variants that are closely related: Fyn, Yes, Blk, Yrk, Frk, Fgr, Srm, Lck and Lyn. 
While Src, Fyn and Yes are ubiquitously expressed, the rest is located in specific cells types4.  
These kinases play key roles in cell morphology, motility (ability of an organism to move 
independently), proliferation and survival, and also participate in many cell signalling pathways. 
The c-Src overexpression and overactivation are associated with several types of human cancer 
like colon, breast or prostate cancer, and several inhibitors of c-Src and SFKs, like Dasatinib, are 
being developed as a compounds for future anticancer drugs5.  
3.3. C-SRC STRUCTURE 
Human c-Src is a non-receptor tyrosine kinase with a molecular mass of ~60 kDa and 
composed by 536 amino acids. From the N-terminus to C-terminus, it contains an SH4 domain, 
a Unique domain, an SH3 domain, an SH2 domain and an SH1 domain, also known as the kinase 
domain. The three last domains are homologous in all the SFKs members. Finally, c-Src also 
contains a 14-carbon myristoyl group attached to the SH4 domain and a C-terminal regulatory 
segment, which are not present in v-Src6. 
 
 
Figure 2. c-Src structure and interactions between domains (image extracted from ref. 7). 
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The function of the myristoylated N-terminal region is to allow the attachment of c-Src to the 
lipid membrane which is essential to carry out its chemical and physical functions7. Myristoylation 
is a modification that takes place directly in the protein nascent chain at the ribosome by the N-
Myristoyl Transferase (NMT) enzyme, which cleaves the initial methionine to create an amide 






Figure 3. N-Myristoylation catalysed by N-Myristoyl Transferase (NMT).  
The SH4 domain is composed of ~15 residues and interacts with acidic lipids (charged 
negatively) because it has three lysines and three arginines that are basic residues (charged 
positively). These also allow the interaction between the SH4 and the SH3 domains, that restricts 
the conformational space of the Unique domain9. 
The next ~65 residues form an intrinsically disordered region (IDR) that connects the SH4 
and SH3 domains and is called Unique domain. Intrinsically disordered regions (IDRs) are 
important constituents of many protein complexes, play various structural, functional and 
regulatory roles, and define the ability of the protein to be involved in polyvalent interactions10. 
This disorder allows the Unique domain of c-Src acting as a regulatory element: for example, 
changing one amino acid in this domain can decrease the invasive capacity of a type of colon 
cancer cells in a 50%. 
This domain presents unique sequences for each member of the SFKs and has an 
additionally lipid binding site known as Unique Lipid Binding Region (ULBR) which interacts with 
acidic lipids, as the SH4 domain, and allows the interactions between the Unique domain and the 
SH3 domain7. 
Adjacent to the Unique domain is the SH3 domain, the first folded domain forming the core 
shared by all SFKs. It is a folded domain composed by ~60 residues organized in a β sandwich 
model made of five antiparallel strands. Between strands β1 – β2 and β2 – β3 are two flexible 
loops, named RT and nSrc respectively, that bind to lipids in addition to the lipid binding regions 
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previously pointed out. These loops allows SH3 interactions with the SH4 and Unique domains, 
which modulate their flexible conformations. Furthermore, the binding of a polyproline peptide (a 
peptide with repeating proline residues) to the SH3 inhibits its interaction with lipids and the 
Unique domain but not with the SH411, as we can see in Figure 4. There is a segment rich in 








Figure 4. SH4-Unique-SH3 interactions in the presence of lipids (image extracted from ref. 11). 
The gray sphere represents the SH3 domain and the black line corresponds to the Unique 
domain, which is connected to the back of the SH3 domain. Residues or regions detected to be 
involved in interactions are indicated and the yellow oval represents the lipid bicelle (not to scale). 
The picture on the left shows SH3, Unique and SH4 domains interactions with lipids: SH4, ULBR 
and the RT and nSrc loops of SH3 are involved in lipid contact, and ULBR – SH3 contacts are 
conserved. On the other hand, the picture on the right shows all these interactions in presence of 
polyproline peptides (pink stick): SH3 – lipids and SH3 – ULBR interactions are abolished, but 
ULBR and SH4 still interact with lipids and the SH4 – SH3 interaction is retained11. 
Towards the C-terminus, it follows the SH2 domain. It is composed of ~100 residues and is 
formed by two α-helix and seven β-strands. It interacts with the phosphorylated Tyrosine 530 of 
the C-terminal regulatory segment for the c-Src regulation6.  
The SH1 domain or Src kinase domain is ~250 residues long and is organized in two parts: a 
small N-terminal lobe which has an antiparallel β-sheet structure and is involved in anchoring and 
orienting ATP, and a large C-terminal lobe which is composed by α-helices and is responsible for 
binding the protein substrate. The catalytic site is situated between the two lobes6.  
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Finally, at the C-terminal end of the SH1 domain is the regulatory segment, composed by ~15 
residues, that contains the residue Tyrosine 530 whose phosphorylation and consequent 
interaction with the SH2 domain is the key in the regulation of c-Src. 
3.3.1. c-Src regulation 
Protein phosphorylation plays a key regulatory role in almost every aspect of eukaryotic cell 
biology. It is a reversible process catalyzed by protein kinases and phosphoprotein phosphatases. 
Protein kinases catalyze the phosphorylation: 
 MgATP1- + protein-OH → protein-OPO32- + MgADP + H+ 
Phosphoprotein phosphatases catalyze the reverse action, the dephosphorylation: 
 Protein-OPO32- + H2O → protein-OH + HOPO32- 
The phosphorylation occurs in a serine, threonine or tyrosine hydroxyl group of the substrate 
protein. SFKs are tyrosine kinases because the phosphorylate residue is a tyrosine12. 
 c-Src and all SFKs members have two important phosphorylation sites: phosphorylation of 









Figure 5. Inactivated and activated states of c-Src (image extracted from ref. 13). 
Inactivation of c-Src occurs when the C-terminal Tyr530 is phosphorylated and interacts with 
the SH2 domain. This also allows the interaction between the SH3 domain and the segment rich 
in proline between SH2 and SH1 domains that results in a closed configuration which do not allow 
the substrates to reach the catalytic site localized in the kinase domain. 
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Activation of c-Src occurs with the removal of the phosphorylated Tyr530 and the consequent 
opening of the structure. To achieve its full activation, needed to start its catalytic activity, there 
must be an autophosphorylation of the Tyr419, localised on the catalytic site13. 
3.4. C-SRC AUTOPROTEOLYSIS 
c-Src, besides being involved in many cellular signalling pathways and playing important roles 
in cell proliferation, is also involved in neuronal development by maintaining some of their 
transmissions. This tyrosine kinase is cleaved at a site in the Unique domain by the protease 
calpain generating a truncated c-Src fragment of ~52 kDa localized predominantly at the cytosol 
which expression induces neuronal death. Because c-Src maintains neuronal survival, calpain 
acts like a molecular switch converting this protein from neuroprotective to neurotoxic14. 
In previous studies realized by the BioNMR Group the same site is cleaved spontaneously in 
the absence of external proteases suggesting an autoproteolytic process triggered by 
conformational changes in the Unique domain, which seem to depend of the environmental 
conditions that influence the interactions between the SH4 domain and the SH3 domain. There 
are many hypothesis about how this proteolysis occurs (tension, groups that catalyze the 
process…), but is not known which one is correct. 
The BioNMR suggests that, as the SH4 domain interacts with phospholipids, the presence of 
phosphate allows the interaction between it and the SH4 domain, releasing the interaction 
between the SH3 and the SH4 domains and reducing the proteolysis of the protein. This 
hypothesis is the one that we will try to prove in this work. 
3.5. O-GLCNACYLATION 
A glycosylation is a reaction in which a carbohydrate is attached to a functional group 
(normally a hydroxyl group) of another molecule. O-GlcNAcylation consists in the addition of a 
uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), which is a derivate of glucose, to the 
Ser or Thr hydroxyl groups of nuclear and cytoplasmic proteins. This reactions follows a SN2 
mechanism and regulates many cellular processes like DNA transcription or cell signalling, but if 
its optimal conditions are modified it can also contribute in many human diseases like cancer, 
diabetes or neurodegeneration15. 
This reaction has some differences with conventional glycosylation: it occurs in the 
nucleoplasm and cytoplasm and the substrate is not modified or elongated to form complex 
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structures16. O-GlcNAcylation is catalyzed by two enzymes: O-GlcNAC transferase or OGT, which 
catalyzes the addition of UDP-GlcNAc, and O-GlcNAcase or OGA, which catalyzes the hydrolysis 










Figure 6. The O-GlcNAcylation cycle (image extracted from ref. 16). 
 
3.5.1. The OGT enzyme 
O-linked N-acetylglucosamine transferase is an enzyme that catalyzes the addition of UDP-
GlcNAc to a serine or a threonine residues on proteins like c-Src following an SN2 mechanism. It 
shows an optimum catalytic activity at pH 6, but below pH 6 or above pH 7.5 its activity decreases 
significantly18. This enzyme contains an initial tail of 6 histidines, known as His-tag, and the 
tetratricopeptide repeat (TPR) which is a degenerate 34 amino acid sequence which can mediate 
its interactions with another proteins and contains the catalytic site19. The OGT that we have used 
contains 4.5 TPR.  
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About its mechanism, OGT follows an SN2 mechanism with inversion of stereochemistry as 
you can see in the following figure: 
Figure 7. Addition of UDP-GlcNAc mechanism (image extracted from Wikipedia Commons). 
3.6. 1H – 15N HSQC 
Heteronuclear single quantum coherence (HSQC) is a highly sensitive 2D-NMR technique 
which is very significant in the field of protein NMR. It was first described in a 1H – 15N system but 
is also applicable to other atomic nucleus such as 1H – 13C system. This technique consists in the 
transfer of magnetization from a proton to the second nucleus (15N or 13C) and, after a time delay, 
the magnetization is transferred back to the proton and a signal is recorded. In 1H – 15N HSQC, 








Figure 8. 1H – 15N HSQC polarization scheme for a protein/amino acid (image extracted from 
Wikipedia Commons). 
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Each residue of a protein has an amide proton attached to a nitrogen in the peptide bond, 
except the proline. This technique provides the correlation between the amide proton and the 
nitrogen, so we obtain an individually peak in the spectra for each residue. Also, the chemical 
shifts are very sensitive to perturbation so any change near the protein will be detected20.  
4. OBJECTIVES 
The main objective of this research is optimizing conditions to study O-GlcNAcylation avoiding 
the protein degradation and observe the interactions of USH3Src with the glycolysis enzyme OGT. 
In order to answer these questions, we define the following objectives: 
• Express and purify the protein construct of USH3Src, and study its degradation in some 
solvents at different temperatures.  
• Express and purify USH3Src with labelled 15N and OGT enzyme, in order to perform 
the O-GlcNAcylation. 
• Study the O-GlcNAcylation reaction using 1H-15N HSQC to observe if the protein has 
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5. EXPERIMENTAL SECTION 
5.1. MATERIALS AND METHODS 
5.1.1. Materials 
Uridine 5’-diphospho-N-acetylglucosamine acid sodium salt (U4375 - 100 mg) purchased 
from Sigma-Aldrich. 
β-Nicotinamide adenine dinucleotide dipotassium salt (N4505 – 100 mg) purchased from 
Sigma-Aldrich. 
The rest of reagents come from stocks stored at -80ºC. 
The compositions of buffers are shown in Appendix 2.  
5.1.1. Instrumental 
Instrument Model Software 
UV-VIS Spectrophotometer Shimadzu UVmini-120 UV Probe 2.42 
FPLC AKTA FPLC W FRAC-950 Unicorn 5.20 
Nickel Cartridge affinity column HisTrapTM HP 1 mL - 
NMR Bruker 600 Ultrashield Plus CCP NMR 
Table 1. Instruments used. 
5.2. OBTAINING OF USH3SRC  
Our USH3Src protein is prepared from a precursor construct that contains: 
 • Histidine tail (His6-tag) for purification purposes. 
 • Glutathione S-transferase (GST) protein to ensure solubility. 
         • TEV protease cleavage site. 
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   • The nature SH4, SH3 and Unique domains. 
The structure of our construction is the following: 
His6-tag --- GST --- TEV --- SH4 --- Unique --- SH3 
The protocols followed for the expression and purification of proteins and enzymes have been 
provided by the BioNMR Research Group of the University of Barcelona21. 
5.2.1. Expression 
The expression of the protein starts from glycerol stocks stored at -80ºC which contains 
Escherichia coli cells transformed by a plasmid that is provided with resistance to the antibiotics 
kanamycin and chloramphenicol. This resistance assure the accurate isolation of USH3Src. 
The procedure starts preparing the preculture media, 3g of Luria Broth (LB) in 100mL, and 
the culture media, 20g of LB in 1L. Luria Broth is a nutritionally rich medium primarily used for the 
growth of bacteria composed by NaCl, yeast extract and tryptone. In this part of the procedure 
sterile conditions are necessary, so both mediums are autoclaved. When the autoclave has 
finished, the antibiotics kanamycin and chloramphenicol (20 µL of 1M per antibiotic) are added to 
the preculture media along with 20 µL of glycerol stock, and we left it shaking at 37ºC for about 
16 hours.   
The following day, 20 mL of the preculture are transferred to the culture media and 0.5 mL of 
each of the previous antibiotics are added. These cultures are incubated at 130 rpm and 37ºC for 
2-3 hours, until the optical density at 600 nm (OD(600nm)) reaches between 0.6 and 0.8. Then, 
isopropyl β-D-1-thiogalactopyranoside (IPTG) at a concentration of 1 mM is added to induce the 
protein expression. Once the induction starts, cultures are incubated at 130 rpm and 25ºC 
overnight but no longer than 18 hours. After the expression period, cultures are collected and 
centrifuged at 4000 rpm for 15 minutes. The supernatant is removed, and the remaining pellet 
resuspended with 20 mL of the corresponding lysis buffer in a sterile 50 mL falcon, which is stored 
at -80ºC until the start of the purification. 
In the expression of USH3Src labelled with 15N, there are two differences. The first one is the 
composition of the culture media: it contains 6 g of Na2HPO4·7H2O, 3 g of KH2PO4, 0.5 g of NaCl 
and 0.5 g of 15NH4Cl in 1L at a pH of 6.8. The second difference is that, aside from the preculture 
and both antibiotics, 1 mL of 1M MgSO4, 1 mL of 1 mg/mL biotin, 1 mL of 1 mg/mL thiamine, 1 
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mL of Q solution (metal traces) and 20 mL of 10% w/v D-glucose are added to the culture media 
before its first incubation. 
5.2.2. Purification 
The resuspended pellet is thawed with water at 4ºC for about 30 minutes and then 
dithiothreitol (DTT) is added at a final concentration of 1 mM. DTT is a reducing agent used to 
avoid intramolecular and intermolecular disulphide bonds between cysteine residues. The pellet 
is sonicated in intervals of 30 seconds ON/OFF each for a total of 150 seconds and repeating it 
three times. Then DNase at a final concentration of 1mM is added to degrade the DNA released 
in the sonication and the sample is centrifuged at 20000 rpm for 45 minutes. The supernatant is 
collected and its pH is observed, which should be above 8 to ensure that the histidines are not 
protonated. If pH is lower than 8, a support buffer is added to ensure that it reaches the desired 
value. The supernatant is purified using the Nickel Cartridge affinity column connected to a 
peristaltic bomb to originate flux though the column in order to capture the protein of interest 
thanks to the presence of the histidine tag, which increases the affinity of the His-tagged protein 
with the column due to the formation of a metal complex with Ni (II). Then it is eluted with an 
elution buffer, which contains a high concentration of imidazole that competes with the interaction 
of the column. The sample is eluted with Lysis buffer though a PD-10 desalting column for the 
separation of high molecular weight substances, like USH3Src, and low molecular weight 
substances, like imidazole, by desalting and exchanging the buffer. Then the eluted sample is 
submitted to the TEV cleavage by adding EDTA, DTT and TEV protease at a ratio of 1:50 and 
leaving it at 4ºC overnight rocking gently, to separate USH3Src from GST. 
Typically, some aggregates are formed during cleavage so after overnight incubation the TEV 
cleavage product is centrifuged at 2000 g for 10 minutes and the supernatant is recovered to 
remove TEV cleavage residues. Once more the Nickel Cartridge affinity column is used to purify 
the protein, but this time releasing the free USH3Src protein in the first flow and retaining the GST 
in the column because it is the construct fragment that contains the histidine tag. The TEV 
protease also has a histidine tag, so is also retained in the Nickel column. Once the separation 
has been carried out, the sample is introduced into the fast protein liquid chromatography (FPLC) 
to finish purifying and isolating the desired protein. When the chromatography has finished, those 
fractions that contain the desired protein (according to the relevant peak of the obtained 
chromatogram) are collected and mixed and will be determined by SDS-PAGE along with some 
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fractions collected during the purification process. SDS-PAGE (sodium dodecyl sulfate-
polyacrylamide gel electrophoresis) is an analytical method in biochemistry used for the 
separation of charged molecules in mixtures by their molecular masses in an electric field using 
sodium dodecyl sulfate (SDS) as a surfactant, covering the proteins’ intrinsic charge and 
conferring them very similar charge-to-mass ratios. Finally, the protein is concentrated using a 
VIVASPIN centrifugal concentrator until reaching the desired concentration, measured with an 
UV spectrophotometer. 
5.3. OBTAINING OF OGT ENZYME  
Our OGT enzyme construct contain 4.5 TPR and an N-terminal His-tag, and has resistance 
to kanamycin due to the plasmid used. 
5.3.1. Expression 
The expression of the enzyme starts from glycerol stocks stored at -80ºC which contains 
Escherichia coli cells transformed by a plasmid that is provided with resistance to the antibiotic 
kanamycin. 
The procedure starts preparing the preculture media, 3g of Luria Broth (LB) in 100mL, and 
the culture media, 1L of Terrific Broth. Terrific Broth is a nutritionally rich medium derived from LB 
that use additional sources of nutrients and an extra amount of buffer to further regulate the pH 
of culture allowing growths to larger ODs and is composed by 4 mL of glycerol, 24 g of yeast 
extract and 20 g of tryptone per litre. It is also composed by 100 mL of a phosphate buffer 
autoclaved (KH2PO4 0.17 M and K2HPO4 0.72 M). In this part of the procedure sterile conditions 
are necessary, so both mediums are autoclaved. When the autoclave has finished, the antibiotic 
kanamycin (20 µL of 1M per antibiotic) is added to the preculture media along with 20 µL of 
glycerol stock, and we left it shaking at 37ºC for about 16 hours.   
The following day, 20 mL of the preculture are transferred to the culture media and 0.5 mL of 
the previous antibiotic are added. These cultures are incubated at 130 rpm and 37ºC for 4-5 
hours, until the optical density at 600 nm (OD(600nm)) reaches between 1.2 and 1.4. Then, isopropyl 
β-D-1-thiogalactopyranoside (IPTG) at a concentration of 0.1 mM is added. Once the induction 
starts, cultures are incubated at 130 rpm and 16ºC overnight but no longer than 18 hours. After 
the expression period, cultures are collected and centrifuged at 4000 rpm for 15 minutes. The 
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supernatant is removed, and the remaining pellet resuspended with 20 mL of the corresponding 
lysis buffer in a sterile 50 mL falcon, which is stored at -80ºC until the start of the purification. 
5.3.2. Purification 
The resuspended pellet is thawed with water at 4ºC for about 30 minutes and then 
dithiothreitol (DTT) is added at a final concentration of 1 mM. The pellet is sonicated in intervals 
of 30 seconds ON/OFF each for a total of 150 seconds and repeating it three times. Then DNAse 
at a final concentration of 1mM is added and the sample is centrifuged at 20000 rpm for 20 
minutes. The supernatant is collected and its pH is observed, which should be above 8 to ensure 
that the histidines are not protonated. If pH is lower than 8, a support buffer is added to ensure 
that it reaches the desired value. The supernatant is purified using the Nickel Cartridge affinity 
column connected to a peristaltic bomb. The His-tag present in the enzyme is bonded to the 
column. Then, a wash is made to remove protein residues of the column with the corresponding 
lysis buffer. Finally, the enzyme is eluted with elution buffer. 
Once the separation has been carried out, the sample is introduced into the fast protein liquid 
chromatography (FPLC) to finish purifying and isolating the desired enzyme. When the 
chromatography has finished, those fractions that contain the desired protein (according to the 
relevant peak of the obtained chromatogram) are collected and mixed and will be determined by 
SDS-PAGE along with some fractions collected during the purification process. Finally, the protein 
is concentrated using a VIVASPIN centrifugal concentrator until reaching the desired 
concentration, measured with an UV spectrophotometer. 
5.4. STUDYING OF USH3SRC DEGRADATION  
In previous studies realized by the BioNMR Group, a spontaneous autoproteolysis of USH3Src 
is noticed. This process seems to depend on the environmental conditions, that influences the 
interactions between the SH4 domain and the SH3 domain. These interactions cause 
conformational changes in the Unique domain, resulting in the rupture and degradation of our 
protein. To study this effect, four different buffers are prepared and the degradation of USH3Src is 
observed collecting fractions through the days and determining them by SDS-PAGE.  
The BioNMR hypothesis for this degradation says that, as the SH4 domain interacts with 
phospholipids, the presence of phosphate allows the interaction between it and the SH4 domain, 
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releasing the interaction between the SH3 and the SH4 domains and reducing the proteolysis of 
the protein. 
The first buffer (Buffer A) used is the one known as Tris Buffer, the most common in 
biochemistry due its buffer range (pH 7 – 9) coincides with the physiological pH of most living 
organisms, with the addition of some components to support the protein survival. The second 
buffer (Buffer B) includes the glycolysis conditions. The third buffer (Buffer C) includes phosphate 
to verify the proposed hypothesis. Finally, the fourth buffer (Buffer D) is the same as Buffer B but 
with the addition of some compounds needed for the correct performance of the O-GlcNAcylation 
reaction but without the OGT enzyme. The compositions of all these buffers are shown in 
Appendix 2. 
5.5. STUDYING OF O-GLCNACYLATION REACTION  
Three different samples were prepared for the studying of this reaction. The first one is the 
reaction sample, which includes 200 µL of USH3Src at 300 µM, 30 µL of Reaction Buffer, 4.6 µL 
of OGT at 120 µM, 6 µL of UDP-GlcNAc at 100 mM and 59.4 µL of Tris Buffer. The compositions 
of buffers are shown in Appendix 2. The second one is the control sample, which has the same 
composition of the reaction sample without UDP-GlcNAc. Finally, the no treated sample, which 
only includes the USH3Src construction in Tris Buffer. All three samples had a final volume of 300 
µL and protein, enzyme and substrate concentrations were equal in all samples. 
Both reaction and control sample were incubated for 90 minutes at 30ºC and a control of both 
reactions was done by collecting fractions and determining them by SDS-PAGE. When the 
incubation was finished, a PD-10 desalting column was used in order to exchange the buffer to 
Tris buffer and assure that all three samples were in the same conditions to improve the accuracy 
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6. RESULTS AND DISCUSSION 
6.1. EXPRESSION AND PURIFICATION RESULTS  
SDS-PAGE is used to verify if the purification has been carried out correctly, using the 
fractions (about 10 µL) that have been collected during the purification.  
6.1.1. Expression and purification of USH3Src 
The purification of USH3Src consists in two Nickel affinity columns, separated by a TEV 











Figure 9. SDS-PAGE showing the first part of the USH3Src protein purification. 
The first sample is the protein marker (M), used to estimate the size of the proteins resolved. 
Cell lysis sample (CL) is after sonification and Supernatant sample (SN) after centrifugation and 
before the first Nickel affinity column. Both samples contain various compounds, including our 
construction among them. During the first Nickel column, everything that does not interact with 
the column is eluted in the flow-through sample (FT1) and our construction is cleaned up with 
 M          CL       SN        FT1      Wa1      El1       PD       TEV 
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lysis buffer in the wash sample (Wa1). In the elution with imidazole (elution buffer), our protein 
with GST is eluted in the elution sample (El1). Fewer salts are observed after the elution of our 
sample though the PD-10 desalting column (PD). Finally, after TEV cleavage (TEV) the rupture 










Figure 10. SDS-PAGE showing the second part of the USH3Src protein purification. 
After doing the second Nickel column, the protein of interest does not interact with the column 
and is eluted in the flow-through sample (FT2). GST remains in the column because of His-tag 
and is cleaned up in the wash sample (Wa2) and eluted by adding imidazole (elution buffer) in 
the elution sample 2 (El2).  
Then, it is proceeded to purify completely the desired protein by means of the FPLC. The 
fractions where the main peak is found are collected according to the obtained chromatogram: in 
our case, from E5 to F1 fraction. Some of these fractions (E5, E8, E10 and F1) are determined 
by SDS-PAGE to assure that the protein has been purified correctly. Finally, a final sample is 
determined after the protein is concentrated using a VIVASPIN centrifugal concentrator. In this 
case we can observe our protein with some GST residues that will not affect our experiments due 
to its low concentration. 
In 15N USH3Src, both expression and purification procedures are the same, so the results are 
equal as in USH3Src. The fractions collected by FPLC are from E6 to F3 fractions, and the 
determined by SDS-PAGE are E6, E8, F1 and F3 fractions. The purification results of the labelled 
protein are shown in Figure 11. 
      M      FT2     El2     Wa2   E5     E8      E10     F1      p-Con 











Figure 11. SDS-PAGE showing the 15N USH3Src protein purification. 
6.1.2. Expression and purification of OGT  
Only one purification by Nickel affinity column is carried out in the purification of OGT enzyme. 










Figure 12. SDS-PAGE showing the OGT enzyme purification. 
Both Cell lysis sample (CL) and Supernatant sample (SN) contain various compounds, 
including our construction among them. During the Nickel column, everything that does not 
interact with the column is eluted in the flow-through sample (FT) and our construction is cleaned 
M     CL   SN   FT1 Wa1 El1  PD  TEV FT2 Wa2 El2  E6    E8     F1     F3 
    M     CL     SN   FT    Wa   El    C10   D7   D10  E2   E4   E9    F1     p-Con 
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up with lysis buffer in the wash sample (Wa). In the elution with imidazole (elution buffer), our 
enzyme is eluted in the elution sample (El). 
Then, it is proceeded to purify completely the enzyme by means of the FPLC. The fractions 
where the main peak is found are collected according to the obtained chromatogram: in our case, 
from C10 to F1 fraction. Some of these fractions (C10, D7, D10, E2, E4, E9 and F1) are 
determined by SDS-PAGE to assure that the protein has been purified correctly. Finally, a final 
sample is determined after the enzyme is concentrated using a VIVASPIN centrifugal 
concentrator. In this case we can observe the enzyme purified with some degradation residues 
that will not affect our reaction. 
6.2. USH3SRC DEGRADATION RESULTS  
SDS-PAGE is used to verify the effect of the degradation in each buffer, using fractions (about 
10 µL) that have been collected through some days.  
6.2.1. Buffer A  
This buffer is composed by Tris Buffer plus some compounds to improve the protein survival: 
EDTA to neutralize metal traces like Ni2+ from the Nickel column and NaN3 as a preservative. One 
fraction per day were collected for seven consecutive days. The degradation was observed at 









Figure 13. SDS-PAGE showing the USH3Src degradation in Buffer A. 
            M   0RT  1RT  2RT 3RT  4RT  5RT  6RT   04    14   24    34    44     54    64   037   137   237   337   437   537    637 
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M is the protein marker. The number is the day when the fraction was collected and the 
subindices the temperature of the sample in the Celsius scale (ºC). 
The information of the SDS-PAGE was converted into numeric data using the ImageJ 
software. This data was normalized and represented in the following graphics:  
Figure 14. Representation of USH3Src concentration and degradation through days at different 
temperatures in Buffer A. The x-axis represents the day and the y-axis the intensity. 
A decrease of USH3Src is observed along with an increase of its degradation through days but 
nothing exceptional.  Degradation increases with the temperature. There are not evidences to 
assure that this buffer affects to USH3Src degradation. 
6.2.2. Buffer B 
This buffer is the one used by the BioNMR Group in order to do the O-GlcNAcylation, 
composed by Tris and Magnesium. The last student who tried to realize this reaction using this 
buffer observed degradation of the protein even before the reaction began. One fraction per day 
were collected for seven consecutive days. The degradation was observed at 4ºC, 37ºC and at 


















0 1 2 3 4 5 6
Src degradation
4ºC RT 37ºC
Autoproteolysis of the Unique domain of Src family proteins  27 
 
Figure 15. SDS-PAGE showing the USH3Src degradation in Buffer B. 
The information of the SDS-PAGE was converted into numeric data using the ImageJ 
software. This data was normalized and represented in the following graphics:  
Figure 16. Representation of USH3Src concentration and degradation through days at different 
temperatures in Buffer B. The x-axis represents the day and the y-axis the intensity. 
A decrease of USH3Src is observed along with an increase of its degradation through days but 
nothing exceptional.  Degradation increases with the temperature. There are not evidences to 
assure that this buffer affects to USH3Src degradation, unlike the last student who tried this and 
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6.2.3. Buffer C 
This buffer has the same composition as Buffer A but using NaH2PO4 and Na2HPO4 instead 
of Tris for the pH regulation. According to the BioNMR Group hypothesis, phosphate interacts 
with the SH4 domain and the interactions between it and the SH3 domain release, decreasing 
the conformational changes on the Unique domain and reducing the protein autoproteolysis. One 
fraction per day were collected for seven consecutive days. The degradation was observed at 
4ºC, 37ºC and at room temperature (RT). The degradation results are shown in Figure 17 and 
Figure 18. 
Figure 17. SDS-PAGE showing the USH3Src degradation in Buffer C. 
The information of the SDS-PAGE was converted into numeric data using the ImageJ 
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A decrease of USH3Src is observed along with an increase of its degradation through days but 
nothing exceptional.  Degradation increases with the temperature. There are not evidences to 
assure that this buffer affects to USH3Src degradation, so we cannot make certain the truthfulness 
of the hypothesis proposed by the BioNMR Group. 
6.2.4. Buffer D 
This buffer has the same composition as Buffer B but with the addition of the compounds 
needed for the correct performance the O-GlcNAcylation reaction (without OGT). These 
compounds are DTT to avoid intramolecular and intermolecular disulphide bonds between 
cysteine residues and allow the O-GlcNAcylation in these residues, and UDP-GlcNAc which is 
the substrate of the reaction. One fraction per day were collected for just four consecutive days, 
as DTT degrades very quickly. The degradation was observed at 4ºC, 37ºC and at room 





Figure 18. Representation of USH3Src concentration and degradation through days at different 
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Figure 19. SDS-PAGE showing the USH3Src degradation in Buffer D. 
The information of the SDS-PAGE was converted into numeric data using the ImageJ 
software. This data was normalized and represented in the following graphics:  
Figure 20. Representation of USH3Src concentration and degradation through days at different 
temperatures in Buffer D. The x-axis represents the day and the y-axis the intensity.  
A decrease of USH3Src is observed along with an increase of its degradation through days but 
nothing exceptional.  Degradation increases with the temperature. There are not evidences to 
assure that the presence of DTT and UDP-GlcNAc affects to USH3Src degradation. 
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6.2.5. Degradation comparison 
To ensure that none of these buffers affects significantly to USH3Src degradation, we 
compared all the data obtained in the same graphic. The 4ºC data is used in this comparison, as 
RT can oscillate significantly and at 37ºC the degradation is so fast. The comparison results are 
shown in the Figure 21. 
Figure 21. Representation of USH3Src degradation through days in different buffers at 4ºC. The x-axis 
represents the day and the y-axis the intensity.  
There are not significant differences in the degradation of USH3Src between buffers. The 
degradation seen is the habitual for all proteins through time. None spontaneous proteolysis 
depending on the environmental conditions has been observed. 
The reason why I didn’t observe an important degradation of the protein like the other students 
who tried this before me is unknown. It can depend of many variables, like the way of working 
with the samples as proteins are very delicate.   
6.3. O-GLCNACYLATION CONTROL  
To assure that the reaction has been carried out without protein degradation, a fraction off 
reaction and control samples were collected at the beginning of the reaction, after 45 minutes, 
and after 90 minutes (end of the reaction). Fractions of three samples after doing the 1H – 15N 
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Figure 22. SDS-PAGE showing the control of the O-GlcNAcylation reaction and the samples after 
RMN. 
Non USH3Src degradation has been observed, so the O-GlcNAcylation reaction seems to be 
carried out correctly. 
6.4. 1H – 15N HSQC RESULTS  
Our objective using this technique is to identify if there are interactions of USH3Src with the 
OGT enzyme and try to identify if the O-GlcNAcylation reaction has been accomplished and which 
are the serines and threonines that contains the glycosylation sites. In order to study that, the 
spectra of the Control sample in front of the no treated sample was studied. The NMR results are 
shown in Figure 23. 
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Figure 23. Comparison of control sample in front of no treated sample using 1H – 15N HSQC.  
The red line corresponds to 3 times the standard deviation of the 10 peaks with less 
perturbations, and it’s used to determine which peaks are significative. Despite that, the scale of 
this spectra is very small (normally is about 0.2 – 0.3) so these perturbations are very low. The 
peaks indicate the chemical shift perturbations (CSP) of each residue. These perturbations are 
caused by a physical change of the Unique domain or by an alteration of the interactions between 
this domain and the OGT enzyme.  
The peaks in the extremes of the spectra are not considered, because they are close to the 
following domains and can be affected by more effects. A region containing three glycines (28G, 
29G and 30G) that have been quite affected by perturbations is found, and this is because 
glycines are very flexible and make this region easier to be disturbed. Many of the perturbed 
residues are serines, which are potential glycosylation sites. In order to confirm that, the spectra 
of the reaction sample in front of the control sample was studied. The NMR results are shown in 
Figure 24. 
Figure 24. Comparison of reaction sample in front of control sample using 1H – 15N HSQC. 
The scale of this spectra is also very small, so these perturbations are also very low. These 
perturbations are caused by a physical change of the Unique domain, by an alteration of the 
interactions between this domain and the OGT enzyme or by the glycosylation of the OGT enzyme 
(some studies have demonstrated that OGT can be glycosylated) that changes the way it interacts 
with the Unique domain.  
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None substantial changes are found in comparison with the previous spectra, so perturbations 
are practically the same in both cases. There are few variations in quantification due to the buffer 
exchange before the analysis of the sample, that modified a little the protein concentration. These 
results mean that the O-GlcNAcylation reaction has not been accomplished and the perturbations 
in our protein are due to its interactions with the OGT enzyme. In order to check this, we observed 






Figure 25. Mass spectrometry spectra of the reaction sample. 
The isotopically averaged molecular weight of our protein is 16125 Da. There are not found 
relevant peaks at higher molecular weight, so we can ensure that the O-GlcNAcylation reaction 
has not been carried out. 
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7. CONCLUSIONS 
The main conclusions obtained from this research are: 
• The USH3Src protein and the 15N USH3Src protein, along with the OGT enzyme, have 
been expressed and purified successfully.  
• No evidences have been found to assure that the environmental conditions influence 
in the USH3Src degradation.  
• In both spectrums obtained by 1H – 15N HSQC and by MS is observed that the O-
GlcNAcylation reaction has not been carried out. 
• Very low interactions between USH3Src and the OGT enzyme have been found using 
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9. ACRONYMS 
Ser   Serine 
Thr   Threonine 
OGT   O-linked-β-D-N-acetylglucosamine transferase 
USH3Src  Unique domain and Src Homologous 3 domain of c-Src 
O-GlcNAc   β-linked N-acetylglucosamine 
TPR   Tetratricopeptide repeat 
OD(600 nm)  Optical density at 600 nm 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
DTT   Dithiothreitol 
UDP-GlcNAc  Uridine diphosphate N-acetylglucosamine 
TEV   Tobacco Etch Virus 
EDTA  Ethylenediaminetetraacetic acid 
GST   Glutathione S-transferase 
FPLC  Fast Protein Liquid Chromatography 
SDS-PAGE  Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
HSQC  Heteronuclear Single Quantum Coherence 
MS   Mass Spectrometry 
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APPENDIX 1: PROTEIN SEQUENCES 
USH3Src sequence: 
G A M G S N K S K P K D A S Q R R R S L E P A E N V H G A G G G A F P A S Q 
T P S K P A S A D G H R G P S A A F A P A A A E P K L F G G F N S S D T V T S 
P Q R A G P L A G G V T T F V A L Y D Y E S R T E T D L S F K K G E R L Q I V N 
N T E G D W W L A H S L S T G Q T G Y I P S N Y V A P S D S I Q A E E 
 
OGT enzyme sequence: 
The initial histidine (H) tail is observed in first amino acids. 
Each colour corresponds to a different TPR, and the grey one corresponds to half TPR. 
M G S S H H H H H H S S G L E V L F Q G P A M C P T H A D S L N N L A N I K R 
E Q G N I E E A V R L Y R K A L E V F P E F A A A H S N L A S V L Q Q Q G K L Q 
E A L M H Y K E A I R I S P T F A D A Y S N M G N T L K E M Q D V Q G A L Q C 
Y T R A I Q I N P A F A D A H S N L A S I H K D S G N I P E A I A S Y R T A L K L 
K P D F P D A Y C N L A H C L Q I V C D W T D Y D E R M K K L V S I V A D Q L E 
K N R L P S V H P H H S M L Y P L S H G F R K A I A E R H G N L C L D K I N V L 
H K P P Y E H P K D L K L S D G R L R V G Y V S S D F G N H P T S H L M Q S I 
P G M H N P D K F E V F C Y A L S P D D G T N F R V K V M A E A N H F I D L S 
Q I P C N G K A A D R I H Q D G I H I L V N M N G Y T K G A R N E L F A L R P A 
P I Q A M W L G Y P G T S G A L F M D Y I I T D Q E T S P A E V A E Q Y S E K L 
A Y M P H T F F I G D H A N M F P H L K K K A V I D F K S N G H I Y D N R I V L 
N G I D L K A F L D S L P D V K I V K M K C P D G G D N A D S S N T A L N M P V 
I P M N T I A E A V I E M I N R G Q I Q I T I N G F S I S N G L A T T Q I N N K A A 
T G E E V P R T I I V T T R S Q Y G L P E D A I V Y C N F N Q L Y K I D P S T L Q 
M W A N I L K R V P N S V L W L L R F P A V G E P N I Q Q Y A Q N M G L P Q N 
R I I F S P V A P K E E H V R R G Q L A D V C L D T P L C N G H T T G M D V L W 
A G T P M V T M P G E T L A S R V A A S Q L T C L G C L E L I A K N R Q E Y E 
D I A V K L G T D L E Y L K K V R G K V W K Q R I S S P L F N T K Q Y T M E L E 
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APPENDIX 2: BUFFERS 
- Lysis buffer Src (pH 8): 
 Trizma® base 20 mM 
 NaCl 300 mM 
 Imidazole 10 mM 
 NaN3 0.01 % 
 DTT 1 mM 
- Lysis buffer OGT (pH 8): 
 Trizma® base 50 mM 
 NaCl 500 mM 
 Imidazole 10 mM 
 Glycerol 2 % 
 DTT 1 mM 
- Support buffer (pH 8): 
This buffer consists in the corresponding lysis buffer and adding Trizma® base at a final 
concentration between 0.5 – 1 M. 
- Elution buffer (pH 8): 
This buffer consists in the corresponding lysis buffer and adding imidazole at a final 
concentration of 400 mM. 
- FPLC buffer Src (pH 7.6): 
 NaH2PO4 8 mM 
 Na2HPO4·7H2O 42 mM 
 NaCl 150 mM 
 EDTA 0.2 mM 
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        NaN3 0.01 % 
              - FPLC buffer OGT (pH 7.6): 
        Trizma® base 50 mM 
         NaCl 300 mM 
        EDTA 0.1 mM 
        Glycerol 1 % 
        DTT 5 mM 
              - Buffer A (pH 7.2): 
        Trizma® base 50 mM 
         NaCl 150 mM 
        EDTA 0.2 mM 
        NaN3 0.01 % 
              - Buffer B (pH 7.2): 
        Trizma® base 75 mM 
         MgCl2 0.5 mM 
              - Buffer C (pH 7.5): 
       This buffer consists in the FPLC buffer for Src. 
              - Buffer D (pH 7.2): 
       This buffer consists in buffer B and adding DTT at a final concentration of 0.2 mM and                                                         
UDP-GlcNAc at a final concentration of 150 mM. 
              - Reaction buffer (pH 7.3): 
        Trizma® base 75 mM 
         NaCl 1.5 M 
        EDTA 6 mM 
        MgCl2 75 mM 
        DTT 3 mM 
 
 
